Thought Leadership
Reddit Stories: AI Failures in Clinical Trials
Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each...
Are Legacy COA Instruments Still Fit for Purpose?
Kathrin Fischer, PhD, and Mark P. Wade discuss whether decades-old COA instruments still reflect how patients live and respond today....
The Human in the Vault: Building Review Workflows That Satisfy Regulators
AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process...
How Indero Explored AI-Assisted Document Processing Through a Targeted Pilot
Learn how Indero piloted TransPerfect Automate to cut manual effort in TMF classification and metadata entry. Across 1,366 documents, 70.3% needed no manual intervention, and the four highest-volume document types hit 100% accuracy. Download the case study to see how AI freed...
eConsent: Why the Content Matters as Much as the Tech
Learn why better eConsent starts with reusable, patient-centered content, not technology alone. ...
Pragmatic Use Cases for AI in Medical Information
The rapid advancement of AI presents medical information teams with powerful new opportunities to transform their operations. From inquiry intake and intelligent triage to case management and standard response development, AI-driven solutions are already delivering measurable...
CSL Behring Streamlines eTMF Document Review
See how CSL Behring is replacing manual eTMF review with real-time, built-in automation....
LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients
Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027,...
Has eCOA Lived up to Its Promise? A Retrospective View on the Evolution of Electronic Clinical Outcome Assessments
Two decades in, electronic clinical outcome assessment has transformed clinical research without fully replacing paper. The next wave of innovation (AI-assisted design, reduced site burden, and true interoperability) could finally change that. Discover where eCOA stands today and...
How a Leading eCOA Provider Cut Timelines by 60% with GlobalLink Strings Integration
Discover how a leading eCOA provider slashed project timelines by 30% and screenshot review cycles by more than 60% by integrating GlobalLink Strings into its platform. This case study breaks down the roadmap, the rollout, and the efficiency gains that followed. See how...
Breaking Down Silos: The Key to Effective Collaboration and Safety Signal Management
Learn how breaking down operational silos across medical information, pharmacovigilance, and regulatory affairs strengthens safety signal management and safeguards patients....
The 5-Step AI Readiness Checklist for Medical Device Manufacturers
Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found...
LifeSci Talks COA Series | eConsent: Why the Content Matters as Much as the Tech
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent...
XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI
Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the...
C3 Summit 2026 - San Francisco
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts....
Regulatory Considerations for Paper COA Translations | What You Need to Know
Managing paper COA translations for global clinical trials means navigating multiple regulatory frameworks that don't share a timeline or coordinate with each other. From ICH E6 and ISPOR guidelines to FDA PRO guidance and copyright licensing requirements, sponsors need to...
When "How Does the Patient Feel?" Became a Regulatory Question
For decades, "how does the patient feel?" was treated as supporting color in a clinical trial, not proof. That's changing fast. FDA guidance for PRO measures has moved patient-reported outcomes from the periphery of trial design toward primary and co-primary...
XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials
Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects...
SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround
In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for...
Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero
Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the...
Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered
CTIS is finally maturing, but staying on top of it is its own job. Between the new transparency framework, the COMBINE and FAST-EU pilots, and the Biotech Act on the horizon, the rules keep shifting. Read this blog to learn what's working, what isn't, and what sponsors...
How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t
Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often...
IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays
Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across...